Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Epoetin Omega in Patients Undergoing Regular Dialysis. Part II: Comparative Trial Versus Epoetin Alfa

NCT00322413 is registered in ClinicalTrials.gov with General Hospital Sveti Duh as lead sponsor.

NCT NCT00322413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00322413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Epoetin Omega in Patients Undergoing Regular Dialysis. Part II: Comparative Trial Versus Epoetin Alfa
Lead sponsor
General Hospital Sveti Duh
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1997
Completion date
April 30, 1997
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, regular dialysis treatment, renal anemia